SEC Form 4 · accession 0001225208-16-036912
BOSTON SCIENTIFIC CORP · BSX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David A Pierce
Officer — SVP and President, Endoscopy
Period of report
Jul 20, 2016
Accepted (ET)
Jul 20, 2016 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 20, 2016 | M | 2,480 | $10.70 | A | 28,080 | D | |
| Common Stock | Jul 20, 2016 | S | 2,480 | $24.03 | D | 25,600 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $10.70 | Jul 20, 2016 | M | 2,480 | D | — | Jul 28, 2019 | Common Stock | 2,480 | 0 | D |
Explanation of responses
- F1This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.
- F2Grant to the reporting person of an option to purchase a specified number of shares of common stock on July 28, 2009. This option is fully vested.